Roberts Darryl 4
4 · AZIYO BIOLOGICS, INC. · Filed Mar 10, 2022
Insider Transaction Report
Form 4
Roberts Darryl
EVP and General Manager, Muscu
Transactions
- Exercise/Conversion
Class A Common Stock
2022-03-08+938→ 3,329 total - Award
Restricted Stock Units
2022-03-08+10,440→ 10,440 total→ Class A Common Stock (10,440 underlying) - Award
Restricted Stock Units
2022-03-08+17,024→ 17,024 total→ Class A Common Stock (17,024 underlying) - Award
Stock Option (Right to Buy)
2022-03-08+37,200→ 37,200 totalExercise: $5.08Exp: 2032-03-08→ Class A Common Stock (37,200 underlying) - Exercise/Conversion
Restricted Stock Units
2022-03-08−938→ 2,812 total→ Class A Common Stock (938 underlying)
Footnotes (7)
- [F1]Restricted stock units convert into shares of Class A Common Stock on a one-for-one basis.
- [F2]Includes 2,391 shares of Class A Common Stock acquired under the Company's 2020 Employee Stock Purchase Plan.
- [F3]The option vests as to 25% of the shares on March 8, 2023 and in 12 equal quarterly installments thereafter, such that the option shall be fully vested and exercisable on March 8, 2026.
- [F4]Each restricted stock unit represents a contingent right to receive one share of Issuer Class A Common Stock.
- [F5]The restricted stock units vest if the Issuer's Class A Common Stock achieves a price per share equal to or greater than $10.00 for any period of thirty (30) consecutive trading days prior to March 8, 2024.
- [F6]On March 8, 2021, the Reporting Person was granted 3,750 restricted stock units, vesting in four substantially equal annual installments beginning on March 8, 2022.
- [F7]The restricted stock units vest on September 8, 2022, subject to the Reporting Person's continuous employment with the Issuer through such vesting date.